Cortagen for Neuroprotection
Research, mechanism, dosing, and effectiveness of Cortagen for neuroprotection.
Quick Answer
Cortagen supports brain health and neuronal function.
Evidence Level
Preclinical
Typical Dose
50-100 mcg daily in cycles
Results Timeline
Neuroprotective effects with continued use
FDA Status
Research Only
How Cortagen Works for Neuroprotection
Brain-targeted bioregulator activity.
About Neuroprotection
Protection of brain cells from damage and neurodegenerative processes.
Research Evidence
Research shows Cortagen activates IL-2 mRNA synthesis in vitro. Studies examined its role in correcting brain metabolic disorders under chronic ischemia. Part of Khavinson's synthesized peptide series with demonstrated effects on ribosome genes and chromatin in elderly subjects.
Dosing for Neuroprotection
Recommended Dose
50-100 mcg daily in cycles
Frequency
Once or twice daily
Administration
Oral capsules or sublingual
Duration
10-30 day cycles
Note: Brain/CNS bioregulator from Khavinson research. Run in cycles.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Limited safety data outside Russia
- •Not FDA approved
Frequently Asked Questions
Does Cortagen help with neuroprotection?
Cortagen supports brain health and neuronal function.
How does Cortagen work for neuroprotection?
Brain-targeted bioregulator activity....
What dose of Cortagen should I use for neuroprotection?
50-100 mcg daily in cycles
How long until I see results?
Neuroprotective effects with continued use
Other Peptides for Neuroprotection
These peptides are also researched for neuroprotection.
Pinealon
PreclinicalA synthetic tripeptide bioregulator targeting brain tissue. Part of Khavinson's peptide research, designed to support cognitive function and neuroprotection.
Livagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
Ovagen
PreclinicalA tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.
Vesugen
PreclinicalA tripeptide bioregulator (Lys-Glu-Asp) targeting vascular tissue. Promotes restoration of blood vessel tissues and normalization of vascular function. Stimulates endothelial cell proliferation markers.
Educational Information Only
This information about Cortagen for neuroprotection is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.